Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension.

Bakris G, Calhoun D, Egan B, Hellmann C, Dolker M, Kingma I; orlistat and resistant hypertension investigators.

J Hypertens. 2002 Nov;20(11):2257-67.

PMID:
12409965
3.
4.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

5.

Review article: malnutrition and maltreatment--a comment on orlistat for the treatment of obesity.

Cahill A, Lean ME.

Aliment Pharmacol Ther. 1999 Aug;13(8):997-1002. Review.

6.

Orlistat: its current status as an anti-obesity drug.

Ballinger A, Peikin SR.

Eur J Pharmacol. 2002 Apr 12;440(2-3):109-17. Review.

PMID:
12007529
7.

Weight management and current options in pharmacotherapy: orlistat and sibutramine.

Leung WY, Thomas GN, Chan JC, Tomlinson B.

Clin Ther. 2003 Jan;25(1):58-80. Review.

PMID:
12637112
8.

New aspects in the management of obesity: operation and the impact of lipase inhibitors.

Uusitupa M.

Curr Opin Lipidol. 1999 Feb;10(1):3-7. Review.

PMID:
10095983
9.

Orlistat.

Wong NN, Cheng-Lai A.

Heart Dis. 2000 Mar-Apr;2(2):174-81. Review.

PMID:
11728255
10.

The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes.

Nelson RH, Miles JM.

Expert Opin Pharmacother. 2005 Nov;6(14):2483-91. Review.

PMID:
16259579
11.

Long-term effects of weight-reducing drugs in hypertensive patients.

Siebenhofer A, Jeitler K, Horvath K, Berghold A, Siering U, Semlitsch T.

Cochrane Database Syst Rev. 2013 Mar 28;3:CD007654. doi: 10.1002/14651858.CD007654.pub3. Review.

PMID:
23543553
12.

Long-term effects of weight-reducing drugs in hypertensive patients.

Siebenhofer A, Horvath K, Jeitler K, Berghold A, Stich AK, Matyas E, Pignitter N, Siering U.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007654. doi: 10.1002/14651858.CD007654.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD007654.

PMID:
19588440
13.

Orlistat--a novel weight loss therapy.

Lucas KH, Kaplan-Machlis B.

Ann Pharmacother. 2001 Mar;35(3):314-28. Review.

PMID:
11261530
14.

Orlistat in the treatment of obesity.

Ballinger A.

Expert Opin Pharmacother. 2000 May;1(4):841-7. Review.

PMID:
11249520
15.

[The obesity epidemics--do diet pills have a place in the treatment?].

Tonstad S, Birkeland KI.

Tidsskr Nor Laegeforen. 2000 Jun 30;120(17):1997-2001. Review. Norwegian.

PMID:
11008533
16.

[Orlistat (Xenical)].

Crenier L, Sternon J.

Rev Med Brux. 1999 Jun;20(3):159-63. Review. French.

PMID:
10429540
17.

Orlistat.

McNeely W, Benfield P.

Drugs. 1998 Aug;56(2):241-9; discussion 250. Review.

PMID:
9711448
18.

[What is the evidence with regard to the effectiveness of orlistat?].

Nordmann A.

Schweiz Med Wochenschr. 2000 Apr 29;130(17):629-34. Review. German.

PMID:
10829301
19.

Orlistat, a new lipase inhibitor for the management of obesity.

Heck AM, Yanovski JA, Calis KA.

Pharmacotherapy. 2000 Mar;20(3):270-9. Review.

PMID:
10730683
20.

Orlistat: a review of its use in the management of obesity.

Hvizdos KM, Markham A.

Drugs. 1999 Oct;58(4):743-60. Review.

PMID:
10551441
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk